title: Complete sustained response of a refractory, post-transplantation, large B-cell lymphoma to an anti-CD22 immunotoxin.
authors.affiliation: National Cancer Institute, National institutes of Health, Bethesda, Maryland, USA.
authors.forename: A M
authors.initials: AM
authors.lastname: Senderowicz
authors.forename: E
authors.initials: E
authors.lastname: Vitetta
authors.forename: D
authors.initials: D
authors.lastname: Headlee
authors.forename: V
authors.initials: V
authors.lastname: Ghetie
authors.forename: J W
authors.initials: JW
authors.lastname: Uhr
authors.forename: W D
authors.initials: WD
authors.lastname: Figg
authors.forename: R M
authors.initials: RM
authors.lastname: Lush
authors.forename: M
authors.initials: M
authors.lastname: Stetler-Stevenson
authors.forename: G
authors.initials: G
authors.lastname: Kershaw
authors.forename: D W
authors.initials: DW
authors.lastname: Kingma
authors.forename: E S
authors.initials: ES
authors.lastname: Jaffe
authors.forename: E A
authors.initials: EA
authors.lastname: Sausville
mesh_terms: D000328:Adult; D015703:Antigens, CD / Q000276:immunology*; D000944:Antigens, Differentiation, B-Lymphocyte / Q000276:immunology*; D015815:Cell Adhesion Molecules; D005260:Female; D005922:Glomerulonephritis, IGA / Q000601:surgery; D004854:Herpesvirus 4, Human; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D037102:Lectins; D016393:Lymphoma, B-Cell / Q000628:therapy* / Q000821:virology; D011183:Postoperative Complications / Q000276:immunology*; D012276:Ricin / Q000627:therapeutic use*; D012307:Risk Factors; D051918:Sialic Acid Binding Ig-like Lectin 2
chemical_list: D015703:Antigens, CD; D000944:Antigens, Differentiation, B-Lymphocyte; C497867:CD22 protein, human; D015815:Cell Adhesion Molecules; D000922:Immunotoxins; D037102:Lectins; D051918:Sialic Acid Binding Ig-like Lectin 2; D012276:Ricin